Form 13-F position report

* DOLBY LABORATORIES INC

Reported by BlackRock Inc

DLB CUSIP 25659T107 Manager CIK 0001364742

Reported 3,138,348 shares, up 14,502 (0.5%) from the prior quarter.

Reported value -8.1%; share count 0.5% vs. the prior quarter.

Added
% of reported 13F value < 0.01% This manager · Q2 2022
Shares 3,138,348 Quarter-end amount reported
Reported value $224,580,000 Fair value at quarter end
Consecutive quarters held 37 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 327772000
2021-12-31 326361000
2022-03-31 244349000
2022-06-30 224580000
2022-09-30 197045000
2022-12-31 219928587
2023-03-31 266412512
2023-06-30 265066995
2023-09-30 457834809
2023-12-31 499644532
2024-03-31 487419592
2024-06-30 458600307
2024-09-30 441124672
2024-12-31 457111188
2025-03-31 484510946
2025-06-30 446998079
2025-09-30 431037692
2025-12-31 391789940
2026-03-31 392692443
2026-06-30 351070612

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for * DOLBY LABORATORIES INC held by BlackRock Inc.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Added 6,676,885 +138,549 (2.1%) < 0.01% $351,070,612 2026-08-07
Q1 2026 Added 6,538,336 +437,589 (7.2%) < 0.01% $392,692,443 2026-05-13
Q4 2025 Added 6,100,747 +144,720 (2.4%) < 0.01% $391,789,940 2026-02-12
Q3 2025 Reduced 5,956,027 -63,338 (-1.1%) < 0.01% $431,037,692 2025-11-12
Q2 2025 Reduced 6,019,365 -13,644 (-0.2%) < 0.01% $446,998,079 2025-08-12
Q1 2025 Added 6,033,009 +180,113 (3.1%) 0.01% $484,510,946 2025-05-02
Q4 2024 Added 5,852,896 +88,821 (1.5%) < 0.01% $457,111,188 2025-02-07
Q3 2024 New 5,764,075 +5,764,075 (0.0%) < 0.01% $441,124,672 2024-11-13
Q2 2024 Reduced 5,788,215 -30,331 (-0.5%) 0.01% $458,600,307 2024-08-13
Q1 2024 Added 5,818,546 +20,861 (0.4%) 0.01% $487,419,592 2024-05-10
Q4 2023 Added 5,797,685 +21,318 (0.4%) 0.01% $499,644,532 2024-02-13
Q3 2023 Added 5,776,367 +2,608,740 (82.4%) 0.01% $457,834,809 2023-11-13
Q2 2023 Added 3,167,627 +48,773 (1.6%) < 0.01% $265,066,995 2023-08-11
Q1 2023 Added 3,118,854 +1,069 (0.0%) < 0.01% $266,412,512 2023-05-12
Q4 2022 Added 3,117,785 +93,311 (3.1%) < 0.01% $219,928,587 2023-02-13
Q3 2022 Reduced 3,024,474 -113,874 (-3.6%) < 0.01% $197,045,000 2022-11-14
Q2 2022 Added 3,138,348 +14,502 (0.5%) < 0.01% $224,580,000 2022-08-12
Q1 2022 Reduced 3,123,846 -303,577 (-8.9%) < 0.01% $244,349,000 2022-05-12
Q4 2021 Reduced 3,427,423 -297,258 (-8.0%) < 0.01% $326,361,000 2022-02-10
Q3 2021 Reduced 3,724,681 -91,782 (-2.4%) < 0.01% $327,772,000 2021-11-09
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

385 managers reported * DOLBY LABORATORIES INC for Q2 2022.

Managers reporting * DOLBY LABORATORIES INC in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Reduced 6,191,117 -66,040 0.01% $443,037,000 37 qtrs
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC Added 4,052,837 +2,183,842 0.92% $290,021,000 9 qtrs
ATLANTA CAPITAL MANAGEMENT CO L L C Reduced 3,738,973 -9,000 1.15% $267,561,000 10 qtrs
Clearbridge Investments LLC Reduced 3,219,426 -99,188 0.21% $230,382,000 37 qtrs
BlackRock Inc This report Added 3,138,348 +14,502 < 0.01% $224,580,000 37 qtrs
Ninety One UK Ltd Reduced 2,662,638 -59,896 0.57% $190,538,000 4 qtrs
Jackson Square Partners LLC Reduced 2,629,576 -751,854 4.39% $188,172,000 7 qtrs
SOMA EQUITY PARTNERS LP Reduced 2,000,000 -300,000 7.57% $143,120,000 8 qtrs
THE BANK OF NEW YORK MELLON CORPORATION Reduced 1,732,557 -45,782 0.03% $123,980,000 37 qtrs
DISCIPLINED GROWTH INVESTORS INC MN Added 1,620,572 +70,265 3.12% $115,968,000 37 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 12, 2022
Filing type
13F-HR
Position type
COM CL A

Voting authority reported

Sole
2,868,949
Shared
0
None
269,399

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.